Promising hybrid procedure aims to tame stubborn AFib

NCT ID NCT04148625

First seen Jun 27, 2026 ยท Last updated Jun 27, 2026

Summary

This study tests a new, less invasive surgical approach for people with persistent atrial fibrillation (AFib), a heart rhythm problem that can be hard to treat. The procedure combines two techniques: ablation (creating tiny scars to block faulty signals) and closing off the left atrial appendage to reduce stroke risk. Researchers are enrolling 100 adults to see if this hybrid method is safe and effective at keeping the heart in normal rhythm without needing extra procedures or long-term drugs.

What this could mean

Our plain-language read of the trial. This is informational only โ€” not medical advice or a prediction.

Active substance
hybrid surgical ablation procedure (epicardial and endocardial ablation plus left atrial appendage exclusion)
What this could lead to
If successful, this could offer a safer, more effective treatment option for people with persistent atrial fibrillation, potentially reducing the need for repeat procedures and long-term medication.
What could go wrong
This is an early-stage registry study with only 100 participants, so results may not apply to everyone. The procedure carries risks like bleeding, infection, or heart injury, and it may not work for all patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ATRIAL FIBRILLATION, PERSISTENT are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

More trials for these conditions

Other studies related to the condition(s) this trial covers.